Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures

Giuseppe Schillaci1, Matteo Pirro, Fabio Gemelli

  • 1Medicina Interna, Angiologia e Malattie da Arteriosclerosi, Policlinico Monteluce, Università degli Studi di Perugia, Via B. Brunamonti 51, 06122 Perugia, Italy. skill@unipg.it

Journal of Hypertension
|September 26, 2003
PubMed

Insights

Newly diagnosed hypertension is linked to higher C-reactive protein (CRP) levels, a marker of inflammation. Both systolic blood pressure and pulse pressure predict CRP levels, independent of other cardiovascular risks.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Biomarkers
  • Hypertension Research

Background:

  • Systemic inflammation, indicated by C-reactive protein (CRP), is increasingly recognized in cardiovascular disease.
  • The relationship between inflammation and newly diagnosed, untreated hypertension requires further elucidation.

Purpose of the Study:

  • To investigate elevated plasma C-reactive protein (CRP) concentrations in patients with newly diagnosed, never-treated hypertension.
  • To determine if blood pressure and pulse pressure correlate with plasma CRP independently of cardiovascular risk factors.

Main Methods:

  • A cross-sectional study was conducted involving 135 newly diagnosed hypertensive patients and 40 healthy controls.
  • Office and 24-hour blood pressure measurements, along with plasma CRP and serum lipid levels, were assessed.

Main Results:

  • Hypertensive patients exhibited significantly higher plasma CRP levels compared to controls (1.85 mg/l vs. 1.01 mg/l).
  • Plasma CRP showed a direct association with systolic blood pressure and pulse pressure, but not diastolic blood pressure, in the overall population and hypertensive patients.
  • Multivariate analysis confirmed systolic blood pressure and pulse pressure as significant predictors of plasma CRP, even after controlling for cardiovascular risk factors.

Conclusions:

  • Systolic blood pressure and pulse pressure are independent predictors of plasma CRP concentrations in newly diagnosed hypertensive patients.
  • These findings suggest a direct link between blood pressure parameters and inflammation, irrespective of traditional cardiovascular risk factors.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Blood Pressure01:24

Blood Pressure

The movement of blood in a human body, commonly referred to as blood flow, is determined by the volume of blood that traverses a certain section of the bodily system per unit time. It is the rhythmic contraction of the heart's ventricles that primarily instigates this movement. As the ventricles contract, blood is forced into the prominent arteries, which then flow from areas of greater pressure to lower pressure areas. This movement continues into smaller arteries and arterioles and...